Mixed Phenotype of Emphysema and Airway Wall Thickening Is Associated with Frequent Exacerbation in Chronic Obstructive Pulmonary Disease Patients

References

• Han MK. Clinical correlations of computed tomography imaging in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2013;10(Suppl):S131–s137. doi:10.1513/AnnalsATS.201303-046AW24313763
   PubMedGoogle Scholar
• Agusti A, Calverley PM, Celli B, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010;11:122. doi:10.1186/1465-9921-11-12220831787
   PubMed Web of Science ®Google Scholar
• Qaseem A, Wilt TJ, Weinberger SE, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011;155(3):179–191. doi:10.7326/0003-4819-155-3-201108020-0000821810710
   PubMed Web of Science ®Google Scholar
• Burrows B, Fletcher CM, Heard BE, Jones NL, Wootliff JS. The emphysematous and bronchial types of chronic airways obstruction. A clinicopathological study of patients in London and Chicago. Lancet. 1966;1(7442):830–835. doi:10.1016/S0140-6736(66)90181-44159957
   PubMed Web of Science ®Google Scholar
• Ogawa E, Nakano Y, Ohara T, et al. Body mass index in male patients with COPD: correlation with low attenuation areas on CT. Thorax. 2009;64(1):20–25. doi:10.1136/thx.2008.09754318852156
   PubMed Web of Science ®Google Scholar
• Kim V, Davey A, Comellas AP, et al. Clinical and computed tomographic predictors of chronic bronchitis in COPD: a cross sectional analysis of the COPDGene study. Respir Res. 2014;15:52. doi:10.1186/1465-9921-15-5224766722
   PubMed Web of Science ®Google Scholar
• Lee JH, Lee YK, Kim EK, et al. Responses to inhaled long-acting beta-agonist and corticosteroid according to COPD subtype. Respir Med. 2010;104(4):542–549. doi:10.1016/j.rmed.2009.10.02419926461
   PubMed Web of Science ®Google Scholar
• Loh LC, Ong CK, Koo HJ, et al. A novel CT-emphysema index/FEV1 approach of phenotyping COPD to predict mortality. Int J Chron Obstruct Pulmon Dis. 2018;13:2543–2550. doi:10.2147/COPD.S16589830174423
   PubMed Web of Science ®Google Scholar
• Van Tho N, Ogawa E, Trang LTH, et al. A mixed phenotype of airway wall thickening and emphysema is associated with dyspnea and hospitalization for chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2015;12(7):988–996. doi:10.1513/AnnalsATS.201411-501OC25844673
   PubMed Web of Science ®Google Scholar
• Subramanian DR, Gupta S, Burggraf D, et al. Emphysema- and airway-dominant COPD phenotypes defined by standardised quantitative computed tomography. Eur Respir J. 2016;48(1):92–103. doi:10.1183/13993003.01878-201527230444
   PubMed Web of Science ®Google Scholar
• Castaldi PJ, Dy J, Ross J, et al. Cluster analysis in the COPDGene study identifies subtypes of smokers with distinct patterns of airway disease and emphysema. Thorax. 2014;69(5):415–422. doi:10.1136/thoraxjnl-2013-20360124563194
   PubMed Web of Science ®Google Scholar
• Lee JS, Ra SW, Chae EJ, et al. Validation of the lower limit of normal diffusing capacity for detecting emphysema. Respiration. 2011;81(4):287–293. doi:10.1159/00027975720110663
   PubMed Web of Science ®Google Scholar
• Lee YK, Oh YM, Lee JH, et al. Quantitative assessment of emphysema, air trapping, and airway thickening on computed tomography. Lung. 2008;186(3):157–165. doi:10.1007/s00408-008-9071-018351420
   PubMed Web of Science ®Google Scholar
• Lim JU, Lee JH, Kim TH, et al. Alternative definitions of chronic bronchitis and their correlation with CT parameters. Int J Chron Obstruct Pulmon Dis. 2018;13:1893–1899. doi:10.2147/COPD.S16405529942122
   PubMed Web of Science ®Google Scholar
• Gevenois PA, de Maertelaer V, De Vuyst P, Zanen J, Yernault JC. Comparison of computed density and macroscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med. 1995;152(2):653–657. doi:10.1164/ajrccm.152.2.76337227633722
   PubMed Web of Science ®Google Scholar
• Amirav I, Kramer SS, Grunstein MM, Hoffman EA. Assessment of methacholine-induced airway constriction by ultrafast high-resolution computed tomography. J Appl Physiol (1985). 1993;75(5):2239–2250. doi:10.1152/jappl.1993.75.5.22398307884
   PubMed Web of Science ®Google Scholar
• Boschetto P, Miniati M, Miotto D, et al. Predominant emphysema phenotype in chronic obstructive pulmonary. Eur Respir J. 2003;21(3):450–454. doi:10.1183/09031936.03.0004870312662000
   PubMed Web of Science ®Google Scholar
• Orlandi I, Moroni C, Camiciottoli G, et al. Chronic obstructive pulmonary disease: thin-section CT measurement of airway wall thickness and lung attenuation. Radiology. 2005;234(2):604–610. doi:10.1148/radiol.234204001315671010
   PubMed Web of Science ®Google Scholar
• Lee HY, Kim JW, Lee SH, et al. Lower diffusing capacity with chronic bronchitis predicts higher risk of acute exacerbation in chronic obstructive lung disease. J Thorac Dis. 2016;8(6):1274–1282. doi:10.21037/jtd27293847
   PubMed Web of Science ®Google Scholar
• Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002;121(5):1434–1440. doi:10.1378/chest.121.5.143412006425
   PubMed Web of Science ®Google Scholar
• Budweiser S, Harlacher M, Pfeifer M, Jorres RA. Co-morbidities and hyperinflation are independent risk factors of all-cause mortality in very severe COPD. COPD. 2014;11(4):388–400. doi:10.3109/15412555.2013.83617424111878
   PubMedGoogle Scholar
• Shin TR, Oh YM, Park JH, et al. The prognostic value of residual volume/total lung capacity in patients with chronic obstructive pulmonary disease. J Korean Med Sci. 2015;30(10):1459–1465. doi:10.3346/jkms.2015.30.10.145926425043
   PubMed Web of Science ®Google Scholar
• Smith BM, Hoffman EA, Basner RC, Kawut SM, Kalhan R, Barr RG. Not all measures of hyperinflation are created equal: lung structure and clinical correlates of gas trapping and hyperexpansion in COPD: the Multi-Ethnic Study of Atherosclerosis (MESA) COPD study. Chest. 2014;145(6):1305–1315. doi:10.1378/chest.13-188424481056
   PubMed Web of Science ®Google Scholar
• Choi JY, Yoon HK, Park SJ, et al. Chronic bronchitis is an independently associated factor for more symptom and high-risk groups. Int J Chron Obstruct Pulmon Dis. 2016;11:1335–1341. doi:10.2147/COPD.S10551627382269
   PubMedGoogle Scholar
• Corhay JL, Vincken W, Schlesser M, Bossuyt P, Imschoot J. Chronic bronchitis in COPD patients is associated with increased risk of exacerbations: a cross-sectional multicentre study. Int J Clin Pract. 2013;67(12):1294–1301. doi:10.1111/ijcp.1224824246208
   PubMed Web of Science ®Google Scholar
• de Oca MM, Halbert RJ, Lopez MV, et al. The chronic bronchitis phenotype in subjects with and without COPD: the PLATINO study. Eur Respir J. 2012;40(1):28–36. doi:10.1183/09031936.0014161122282547
   PubMed Web of Science ®Google Scholar
• Yoo SH, Lee JH, Yoo KH, Jung KS, Rhee CK. Different pattern of chronic obstructive pulmonary disease assessment test score between chronic bronchitis and non-chronic bronchitis patients. Tuberc Respir Dis (Seoul). 2018;81(3):228–232. doi:10.4046/trd.2017.008829527842
   PubMed Web of Science ®Google Scholar
• Fujimoto K, Kitaguchi Y, Kubo K, Honda T. Clinical analysis of chronic obstructive pulmonary disease phenotypes classified using high-resolution computed tomography. Respirology. 2006;11(6):731–740. doi:10.1111/res.2006.11.issue-617052301
   PubMed Web of Science ®Google Scholar